Following the success of the first and second Frontiers in Cancer Science conference, our third annual conference was held from 31 October to 3 November 2011 at the University Cultural Centre (UCC) Theatre in NUS.
This conference was hosted by the Cancer Science Institute of Singapore (CSI Singapore) at NUS and jointly organized by Duke-NUS Graduate Medical School, Genome Institute of Singapore, Institute of Molecular and Cell Biology, National Cancer Centre Singapore and the National University Cancer Institute, Singapore.
The conference, which witnessed the convergence of local and overseas cancer research experts and authorities, including an impressive list of partnering schools and institutes, saw an overwhelming response with 10 per cent oversubscription and about 500 attendees in all.
The event opened with a Welcome Address by our Director, Prof. Daniel G. Tenen and was followed by a Keynote talk by Prof. Joseph Schlessinger, Chair of Pharmacology and Director of the Cancer Biology Institute at Yale School of Medicine, which discussed the “Cell Signaling By Receptor Tyrosine Kinases: From Basic Principles to Cancer Therapy”. Other eminent speakers featured included Prof. Mina Bissell, Distinguished Scientist at the Lawrence Berkeley National Laboratory; and Prof. Frank McCormick, Director at the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center. Participation by these international leaders of cancer research greatly boosted the extent of the scientific engagement and exchange at the conference.
Besides the talks, there were posters and oral presentations by students, post-doctoral researchers and other budding scientists from Singapore and Asia. Being the 3rd annual conference, the Frontiers in Cancer Science 2011 has further established itself as a premier gathering of cancer experts in the region which promotes in-depth discussions and sharing on cancer-related research.